Bio Decontamination Market By Product & Service (Equipment, Consumables, and Services), By Agent Type (Nitrogen Dioxide, Hydrogen Peroxide, Peracetic Acid, and Chlorine Dioxide), By Type (Chamber Decontamination and Room Decontamination), By End-user (Hospitals & Healthcare Facilities, Life Sciences & Biotechnology Research Organizations, and Pharmaceutical & Medical Device Manufacturing Companies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Report Overview

The Bio Decontamination Market Size is expected to be worth around USD 405.5 Million by 2033 from USD 237.4 Million in 2023, growing at a CAGR of 5.5% during the forecast period 2024 to 2033.

Bio-decontamination involves eliminating harmful microorganisms using physical and chemical methods. This essential step occurs in manufacturing facilities, healthcare settings, and research organizations to prevent microbial transmission and ensure sterile end products. Factors driving demand include investments by pharmaceutical and medical device manufacturers, as well as stringent regulations to prevent contamination.

Facilities such as animal labs, fermentation suites, and cleanrooms require high cleanliness levels. Furthermore, as healthcare facilities face a direct risk of bio-contamination due to the presence of patients with various ailments, there is a high demand for bio decontamination services and equipment to ensure patients’ and healthcare professionals’ safety from hospital-acquired infections.

A study published in the Lancet in September 2021 highlighted the rise in hospital-acquired infections (HAIs) among patients admitted to hospitals in the United Kingdom. Specifically, over 11.3% of patients with COVID-19 in 314 UK hospitals acquired infections after admission, and this rate increased to 15.8% during the pandemic. Additionally, 6.8% of all COVID-19 patients developed nosocomial infections, which rose to 8.2% during the pandemic.

Key Takeaways

• In 2023, the market for bio decontamination generated a revenue of USD 4 million, with a CAGR of 5.5%, and is expected to reach USD 405.5 million by the year 2033.
• The product & service segment is divided into equipment, consumables, and services, with equipment taking the lead in 2023 with a market share of 44.1%.
• Considering agent type, the market is divided into nitrogen dioxide, hydrogen peroxide, peracetic acid, and chlorine dioxide. Among these, hydrogen peroxide held a significant share of 3%.
• In type segment, the chamber decontamination sector stands out as the dominant segment, holding the largest revenue share of 56.7% in the bio decontamination market.
• The end-user segment the pharmaceutical & medical device manufacturing companies segment leading the market, holding a revenue share of 43.1%.
• North America lead the market by securing a market share of 42.1% in 2023.

Product & Service Analysis

The equipment segment led in 2023, claiming a market share of 44.1% owing to its extensive use and high demand. Specialized bio-decontamination equipment plays a crucial role in effectively and efficiently decontaminating surfaces, equipment, and environments.

Employing cutting-edge technologies such as vaporized hydrogen peroxide (VHP), ozone, ultraviolet (UV) light, or dry heat, these systems prioritize safety for operators and the environment. Their versatility allows them to be used in various settings, including pharmaceutical clean rooms, hospital operating rooms, laboratories, and food processing plants.

Agent Type Analysis

Hydrogen peroxide held a significant share of 34.3% as it demonstrates broad-spectrum antimicrobial activity, effectively eliminating bacteria, viruses, fungi, and spores. Its rapid action upon contact ensures swift decontamination, minimizing downtime.

Importantly, hydrogen peroxide decomposes into water and oxygen without leaving harmful residues, making it a safe choice for bio-decontamination processes and driving market growth. For instance, STERIS, one of the prominent market players, introduced hi-tech integrated VHP (vaporized hydrogen peroxide) bio decontamination systems in September 2021 that were tailored for customers to achieve significant reduction in bioburden within medical devices, pharmaceuticals, and research settings.

Type Analysis

The chamber decontamination segment had a tremendous growth rate, with a revenue share of 56.7% as the chamber decontamination systems are specifically designed to treat entire enclosed spaces, ensuring thorough coverage of all surfaces and hard-to-reach areas within the chamber.

By utilizing mechanisms such as vaporization, aerosols, or gaseous distribution, these systems achieve uniform dispersion of decontaminating agents throughout the enclosed space. As a result, they offer efficient and time-saving solutions for large-scale decontamination tasks. Compared to labor-intensive manual cleaning methods, chamber decontamination allows simultaneous treatment of multiple surfaces and areas within the chamber, reducing overall downtime and labor costs.

End-user Analysis

The pharmaceutical & medical device manufacturing companies segment grew at a substantial rate, generating a revenue portion of 43.1%. Pharmaceutical and medical device manufacturers face stringent regulatory requirements from agencies such as the FDA and EMA.

Effective bio-decontamination processes are crucial for compliance with good manufacturing practices (GMP) and other standards. These companies invest in advanced technologies and equipment, including UV-C disinfection devices, hydrogen peroxide vapor generators, and ozone sterilizers, to efficiently eliminate biological contaminants. These innovations contribute to the growth of the bio-decontamination market segment.

Key Market Segments

By Product & Service

• Equipment
• Consumables
• Services

By Agent Type

• Nitrogen Dioxide
• Hydrogen Peroxide
• Peracetic Acid
• Chlorine Dioxide

By Type

• Chamber Decontamination
• Room Decontamination

By End-user

• Hospitals & Healthcare Facilities
• Life Sciences & Biotechnology Research Organizations
• Pharmaceutical & Medical Device Manufacturing Companies

Drivers

Rising Prevalence of Hospital-acquired Infections

The surge in the occurrence of hospital-acquired infections is expected to drive the market during the forecast period due to the increase in demand for effective decontamination solutions. The hospital-acquired infections pose a significant threat to patients, leading to prolonged hospital stays, increased healthcare costs, and high mortality rates. To combat this, hospital facilities are adopting advanced bio-decontamination technologies. This shift towards more effective decontamination methods boosts the market.

• According to data published by the United States Department of Health & Human, acute care hospitals in the US recorded 30,389 catheter line-associated bloodstream infections in 2021. Additionally, over 1,995 cases of ventilator-associated infections were reported by these hospitals during the same year.

Restraints

Rise in Product Recalls

Despite the introduction of technologically advanced decontamination products, an increase in voluntary recalls due to damaged or compromised quality is expected to limit their adoption. Consequently, consumers may shift their preference to other available products, hindering market growth. Additionally, certain limitations such as the short shelf life of disinfectants and potential corrosion from chlorine-based products are also likely to impact market expansion.

For instance, according to the FDA, in December 2022, Steris Corporation recalled its VERIFY Dual Species Self-Contained Biological Indicators. The inconsistent spore results for G. stearothermophilus and B. atrophaeus prompted this recall, highlighting the importance of product quality in maintaining safety standards.

Opportunities

Growing Requirement for Bio Decontamination Services in the Pharmaceutical and Biotechnology Industry

The growing demand for effective bio decontamination in pharmaceutical and biotechnology facilities is expected to create lucrative prospects for the market. This demand is driven by the increasing production of biologics and biosimilars, rising regulatory scrutiny, and growing awareness of contamination control’s importance.

To address this need various companies are offering specialized bio decontamination services such as vaporized hydrogen peroxide (VHP) and hydrogen peroxide gas plasma (HPGP). These solutions help ensure product integrity and compliance with regulatory standards. According to an article published by NCBI in March 2022, hydrogen peroxide-based decontamination technologies are widely used. When combined with advancements in delivery systems, they demonstrate efficacy comparable to traditionally employed methods.

Impact of Macroeconomic / Geopolitical Factors

Macroeconomic and geopolitical factors exert a significant influence on the bio decontamination market, shaping its growth trajectory and dynamics. Macroeconomic factors such as government investments in infection control and increasing healthcare expenditure are projected to create profitable projections for the market.

Geopolitical factors such as trade agreements and global health initiatives also drive the market by facilitating access to new markets and technologies. However, trade restrictions and economic downturns are likely to limit market expansion to a certain extent.

Trends

Integration of Advanced Technologies

The integration of advanced technologies is expected to create lucrative prospects for the market during the assessment period. Various key market players are focusing on the development of innovative solutions that combine multiple technologies to enhance the effectiveness and efficacy of the bio decontamination systems.

For instance, the use of hydrogen peroxide vaporization and UV light disinfection is becoming increasingly popular due to its ability to provide extensive decontamination. These advanced technologies offer reliability, shorter cycle times, and better safety, making them beneficial for the pharmaceutical and biotech industries.

• In September 2021, Steris unveiled the next generation of vaporized hydrogen peroxide (VHP) bio-decontamination systems. These systems achieve a 6-log reduction in bioburden and are used in pharmaceuticals, medical devices, and research facilities. They can be seamlessly integrated into a facility’s building automation, allowing decontamination cycles to be run at programmed intervals or with a simple button press.

Regional Analysis

North America is leading the bio decontamination Market

North America led the market with the highest revenue share of 42.1% owing to the presence of advanced medical infrastructure and high healthcare expenditure. This substantial investment encourages the adoption of state-of-the-art bio decontamination solutions in healthcare facilities across the region.

This region also has a large number of pharmaceutical, biopharmaceutical, and biotechnology companies that employ the use of bio decontamination agents on a regular basis and make heavy investments in this space. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), the U.S. biopharmaceutical industry allocated approximately US$ 102.3 billion to research and development in 2021.

This significant investment and sectoral growth directly correlate with the rising demand for bio decontamination solutions to uphold sterile environments in research and manufacturing settings.

The Asia Pacific region is expected to experience the highest CAGR during the forecast period

The Asia-Pacific region is experiencing rapid expansion in its healthcare facilities, leading to heightened demand for bio decontamination products and services. According to the Asian Development Bank, healthcare spending in this region is projected to reach US$ 2.4 trillion by 2030, growing at a compound annual growth rate (CAGR) of 6.3% between 2014 and 2030.

This substantial investment in healthcare infrastructure underscores the need for cutting-edge bio decontamination solutions to maintain sterile environments and prevent infections. Additionally, the robust growth of the pharmaceutical and biotechnology sectors in the Asia Pacific region is driving increased demand for bio decontamination services. According to the popular Indian newspaper, The Hindu, the Indian pharmaceutical sector alone is expected to be valued at US$ 130 billion by 2030.

Key Regions and Countries

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Russia
  • Netherland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • New Zealand
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA

Key Players Analysis

The major players in the bio decontamination market are actively engaged in the development and introduction of innovative products, as well as implementing strategic initiatives aimed at enhancing their competitive positioning. These companies are expanding their operations in emerging markets and releasing new products to cater to the growing demand for bio decontamination products and services.

For instance, In December 2021, TOMI Environmental Solutions, Inc., a global disinfection and decontamination company, introduced the SteraMist Amazon Store. The store includes the SteraPak and Binary Ionization Technology (BIT). The SteraPak utilizes SteraMist’s ionized Hydrogen Peroxide (iHP) disinfection technology, providing a powerful disinfectant that is quick, non-corrosive, and easy to use without the need for mixing, wiping, or rinsing.

Top Key Players in the Bio Decontamination Market

• Vaisala
• TOMI Environmental Solutions, Inc
• Tecomak
• STERIS Corporation
• Scanbur A/S
• PDI Technologies Inc.
• Noxilizer
• JCE BIOTECHNOLOGY
• Howorth Air Technology Limited
• Fedegari,
• Ecolab
• DIOP GmbH
• ClorDiSys Solutions Inc
• Amira S.r.l.
• M. Instruments S.R.L.

Recent Developments

• In August 2022, PDI Technologies Inc. launched novel disinfectants, including Sani-HyPerCide Germicidal Disposable Wipe, Sani-24 Germicidal Disposable Wipe, and Sani-HyPerCide Germicidal Spray. These products aim to combat the rise of healthcare-associated infections (HAIs).
• In September 2021, STERIS partnered with H+E Pharma to create end-to-end, turnkey clean utility water systems. These systems are designed for life science pharmaceutical and biotechnology applications in the European market.

Report Scope